Fibroblast Growth Factor Receptor 3 Mutation as a Prognostic Indicator in Patients with Urothelial Carcinoma: A Systematic Review and Meta-analysis

Fibroblast Growth Factor Receptor 3 Mutation as a Prognostic Indicator in Patients with Urothelial Carcinoma: A Systematic Review and Meta-analysis

Background: Fibroblast growth factor receptor 3 (FGFR3) mutations have been implicated in urothelial tumorigenesis. FGFR3 inhibitors are being explored in clinical trials. Objective: We aimed to study the association between FGFR3 mutations and survival in urothelial carcinoma. Design, setting, and...

Full description

Bibliographic Details
Main Authors:	Sidra Khalid, Bassam Mohammed Basulaiman, Jeffrey Emack, Christopher M. Booth, Ignacio Duran, Andrew G. Robinson, David Berman, Martin Smoragiewicz, Eitan Amir, Francisco E. Vera-Badillo
Format:	Article
Language:	English
Published:	Elsevier 2020-10-01
Series:	European Urology Open Science
Subjects:	Fibroblast growth factor receptor 3 mutation Muscle invasive Non-muscle invasive Progression-free survival Recurrence-free survival Urothelial carcinoma
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666168320353179

Similar Items

Is en-bloc transurethral resection of bladder tumor for non-muscle invasive bladder carcinoma better than conventional technique in terms of recurrence and progression?: A prospective study
by: Sanjoy Kumar Sureka, et al.
Published: (2014-01-01)

The prognostic significance of androgen receptor and β-catenin immunohistochemical expression in urothelial carcinoma with and without detrusor muscle invasion from an Egyptian institution
by: Shaimaa Elzamy, et al.
Published: (2018-11-01)

Association of Tumour Location and Recurrence in Patients with Non-Muscle Invasive Bladder Cancer
by: Ilaria Jansen, et al.
Published: (2020-11-01)

The role of neutrophil to lymphocyte ratio in patients with pTa non-muscle invasive bladder cancer
by: Mártha Orsolya, et al.
Published: (2020-01-01)

From clinical trials to the front line: Vinflunine for Treatment of UrothelialCell Carcinoma at the National Cancer Institute of Naples
by: GAETANO eFACCHINI, et al.
Published: (2016-05-01)

Evaluation of the Expression of HER2 and c-KIT Proteins as Prognostic Markers in Superficial Bladder Urothelial Carcinoma
by: Abdou Hassan W, et al.
Published: (2021-05-01)

Effectiveness of transurethral resection under the control of photodynamic diagnosis and intravesical instillation of bacillus Calmette–Guérin in case of poorly differentiated non-muscle-invasive bladder cancer
by: A. I. Rolevich
Published: (2016-09-01)

Efficacy and safety of adjuvant therapy with nivolumab or placebo in high-risk patients with muscle-invasive urothelial carcinoma after radical surgery: review of the first results of the randomized phase III trial CheckMate 274
by: M. I. Volkova, et al.
Published: (2021-05-01)

Metastatic Urothelial Carcinoma of the Prepuce and Glans Penis: Suspected Implantation of Non-Muscle-Invasive Bladder Cancer via Urine
by: Tomoyuki Makino, et al.
Published: (2014-07-01)

SURVIVAL OF PATIENTS WITH BLADDER CANCER WHO HAD PARTIAL CYSTECTOMY IS BETTER THAN THOSE WHO HAD RADIOTHERAPY
by: Denny Achmad Prayoga, et al.
Published: (2017-03-01)

FOXO3A Expression in Upper Tract Urothelial Carcinoma
by: Guoyao Zhang, et al.
Published: (2021-04-01)

The Significance of Fibrosis Quantification as a Marker in Assessing Pseudo-Capsule Status and Clear Cell Renal Cell Carcinoma Prognosis
by: Caipeng Qin, et al.
Published: (2020-11-01)

Effect of docetaxel + oxaliplatin + S-1 and docetaxel + cisplatin + fluorouracil on treatment of advanced gastric cancer
by: Wei Li, et al.
Published: (2016-09-01)

Urinary expression of let-7c cluster as non-invasive tool to assess the risk of disease progression in patients with high grade non-muscle invasive bladder Cancer: a pilot study
by: Manuela Spagnuolo, et al.
Published: (2020-04-01)

Preoperative prognostic nutritional index and nomogram predicting recurrence-free survival in patients with primary non-muscle-invasive bladder cancer without carcinoma in situ
by: Cui J, et al.
Published: (2017-11-01)

Prognostic significance of epidermal growth factor receptor (EGFR) over expression in urothelial carcinoma of urinary bladder
by: Atif Ali hashmi, et al.
Published: (2018-06-01)

Outcomes of radical cystectomy and bladder preservation treatment for muscle-invasive urothelial carcinoma of the bladder
by: Wempy Supit, et al.
Published: (2014-10-01)

Transperineal cryotherapy for unresectable muscle invasive bladder cancer: preliminary experience with 7 male patients
by: Qing Zhang, et al.
Published: (2017-09-01)

Impact of a surgeon on the relapse-free survival of patients with non-muscle-invasive bladder cancer
by: A. I. Rolevich
Published: (2016-06-01)

The impact of perivesical lymph node metastasis on clinical outcomes of bladder cancer patients undergoing radical cystectomy
by: Meenal Sharma, et al.
Published: (2019-08-01)

Profiling the Biological Characteristics and Transitions through Upper Tract Tumor Origin, Bladder Recurrence and Muscle-Invasive Bladder Progression in Upper Tract Urothelial Carcinoma
by: Kikuchi, E., et al.
Published: (2022)

Oncological Outcomes of Adjuvant Radiotherapy for Partial Ureterectomy in Distal Ureteral Urothelial Carcinoma Patients
by: Hong-zhen Li, et al.
Published: (2021-09-01)

Evaluation of topoisomerase II, ki-67, and P53 expression in non-muscle-invasive urothelial carcinoma and their clinical significance
by: Noha Elkady, et al.
Published: (2018-01-01)

Prognostic factors and survival study in high-grade glioma in a hospital in Lima, Peru
by: Paul Méndez-Aguilar, et al.
Published: (2020-07-01)

REPEAT TRANSURETHRAL RESECTION OF THE BLADDER AND THE RESULTS OF TREATMENT IN PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER
by: A. V. Semenov, et al.
Published: (2014-07-01)

REPEAT TRANSURETHRAL RESECTION OF THE BLADDER AND THE RESULTS OF TREATMENT IN PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER
by: A. V. Semenov, et al.
Published: (2014-07-01)

Expression and Role of GPR87 in Urothelial Carcinoma of the Bladder
by: Yoshiyuki Kakehi, et al.
Published: (2013-06-01)

EFFICIENCY OF BEAM RADIOTHERAPY FOR NON-MUSCLE-INVASIVE BLADDER CANCER
by: K. N. Safiullin, et al.
Published: (2014-07-01)

EFFICIENCY OF BEAM RADIOTHERAPY FOR NON-MUSCLE-INVASIVE BLADDER CANCER
by: K. N. Safiullin, et al.
Published: (2014-07-01)

Prognostic impact of p16 and p53 gene expressions in stage 1a epithelial ovarian cancer
by: Emre Günakan, et al.
Published: (2020-07-01)

Evolution of Urothelial Bladder Cancer in the Context of Molecular Classifications
by: Martina Minoli, et al.
Published: (2020-08-01)

Telomere instability in papillary bladder urothelial carcinomas: Comparison with grading and risk of recurrence
by: Giuseppe Mucciardi, et al.
Published: (2014-01-01)

Clinicopathological Features and Survival Outcomes of Primary Pulmonary Invasive Mucinous Adenocarcinoma
by: Chien-Hung Gow, et al.
Published: (2021-08-01)

Minimally-Invasive Versus Abdominal Hysterectomy for Endometrial Carcinoma With Glandular or Stromal Invasion of Cervix
by: Jihee Jung, et al.
Published: (2021-05-01)

Prognostic role of lymphovascular invasion and lymph node status among breast cancer subtypes
by: Guo-Shiou Liao, et al.
Published: (2018-01-01)

Integrative Transcriptome Profiling Reveals <i>SKA3</i> as a Novel Prognostic Marker in Non-Muscle Invasive Bladder Cancer
by: Chaelin You, et al.
Published: (2021-09-01)

GATA3 and CK5/6 Immunohistochemical Expression in Urothelial Carcinoma: Diagnostic, Biological and Prognostic Significance
by: Marwa Abdel Moneim El Kholy, et al.
Published: (2021-04-01)

Determinants of Survival and Post-Progression Outcomes by Sorafenib–Regorafenib Sequencing for Unresectable Hepatocellular Carcinoma
by: Chao, Y., et al.
Published: (2022)

Survival after radiotherapy versus radical cystectomy for primary muscle‐invasive bladder cancer: A Swedish nationwide population‐based cohort study
by: Christel Häggström, et al.
Published: (2019-05-01)

LARGE PAPILLARY UROTHELIAL NEOPLASM OF LOW MALIGNANT POTENTIAL: A CASE REPORT
by: A. A. Tomilov, et al.
Published: (2018-10-01)